Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights

JACC: Cardiovascular Imaging

Volumn 12, Issue 6, 2019, Pages 993-1003

  Haig, Caroline ^a   Carrick, David ^b,c   Carberry, Jaclyn ^b,c   Mangion, Kenneth ^b,c   Maznyczka, Annette ^b,c   Wetherall, Kirsty ^a   McEntegart, Margaret ^c   Petrie, Mark C ^c   Eteiba, Hany ^c   Lindsay, Mitchell ^c   Hood, Stuart ^c   Watkins, Stuart ^c   Davie, Andrew ^c   Mahrous, Ahmed ^c   Mordi, Ify ^b,c   Ahmed, Nadeem ^b,c   Teng Yue May, Vannesa ^b,c   Ford, Ian ^a   Radjenovic, Aleksandra ^b   Welsh, Paul ^b   Sattar, Naveed ^b   Oldroyd, Keith G ^b,c   Berry, Colin ^b,c   more..

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

cigarette smoking; magnetic resonance imaging; microcirculation; myocardial hemorrhage; myocardial infarction; prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; GADOLINIUM; INTERLEUKIN 6; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLEEDING; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CIGARETTE SMOKING; CLINICAL OUTCOME; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART EDEMA; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; NEUTROPHIL COUNT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADVERSE EVENT; AGED; CARDIAC MUSCLE; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; HEART VENTRICLE REMODELING; MICROCIRCULATION; MORTALITY; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; CORONARY CIRCULATION; EDEMA, CARDIAC; FEMALE; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKERS; SMOKING; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 85066100594     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2018.05.022     Document Type: Article

References (44)

1. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. Writing Group Members Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
3. Burke, A.P., Farb, A., Malcom, G.T., Liang, Y.H., Smiale, J., Virmani, R., Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336 (1997), 1276–1282.
4. Barau, R.S., Ambrose, J.A., Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol 33 (2013), 1460–1467.
5. Folts, J.D., Bonebrake, F.C., The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 65 (1982), 465–470.
6. Barua, R.S., Sy, F., Srikanth, S., et al. Effect of cigarette smoke exposure on clot dynamics and fibrin structure: an ex-vivo investigation. Arterioscler Thromb Vasc Biol 30 (2010), 75–79.
7. Kelly, T.L., Gilpin, E., Ahnve, S., Henning, H., Ross, J. Jr., Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 110 (1985), 535–541.
8. Grines, C.L., Topol, E.J., O'Neill, W.W., et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 91 (1995), 298–303.
9. Weisz, G., Cox, D.A., Grcia, E., et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction—the smoker's paradox revisited. Am Heart J 150 (2005), 358–364.
10. Weisz, G., Cox, D.A., Garcia, E., et al. Effect of smoking on infarct size and major adverse cardiac events in patient with large anterior ST-elevation myocardial infarction (from the INFUSE-AMI trial). Am J Cardiol 118 (2016), 1097–1104.
11. Saad, M., Fuernau, G., Desch, S., et al. “Smoker's paradox” in patients with cardiogenic shock complicating myocardial infarction—a substudy of the IABP-SHOCK II-trial and registry. Int J Cardiol 222 (2016), 775–779.
12. Reinstadler, S.J., Eitel, C., Fuernau, G., et al. Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST- elevation myocardial infarction. Eur Heart J Cardiovasc Imaging 18 (2017), 39–45.
13. Gerber, Y., Rosen, L.J., Goldbourt, U., Benyamini, Y., Drory, Y., for the Israel Study Group on First Acute Myocardial Infarction. Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study. J Am Coll Cardiol 54 (2009), 2382–2387.
14. Stone, G.W., Selker, H.P., Thiele, H., et al. Relationship between infarct size and outcome following primary-PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol 67 (2016), 1674–1683.
15. Mons, U., Müezzinler, A., Gellert, C., et al., for the CHANCES Consortium. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ, 350, 2015, h1551.
16. Symons, R., Masci, P.G., Francone, M., et al. Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: the smoker's paradox revisited. Eur Heart J 37 (2016), 2756–2764.
17. Eitel, I., Kubusch, K., Strohm, O., et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation myocardial infarction. Circ Cardiovasc Imaging 4 (2011), 354–362.
18. Carrick, D., Haig, C., Ahmed, N., et al. Myocardial hemorrhage after acute reperfused ST-segment elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging, 9, 2016, e004148.
19. McGeoch, R., Watkins, S., Berry, C., et al. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 3 (2010), 715–722.
20. Payne, A.R., Berry, C., Doolin, O., et al. Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction. J Am Heart Assoc, 1, 2012, e002246.
21. Carrick, D., Haig, C., Carberry, J., et al. Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1, 2016, e85768.
22. Carrick, D., Haig, C., Ahmed, N., et al. Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment elevation myocardial infarction. Circulation 134 (2016), 1833–1847.
23. Fearon, W.F., Shah, M., Ng, M., et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 51 (2008), 560–565.
24. Fearon, W.F., Low, A.F., Yong, A.S., et al. Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation 127 (2013), 2436–2441.
25. O'Gara, P.T., Kushner, F.G., Ascheim, D.D., et al., for the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61 (2013), e78–e140.
26. Centers for Disease Control and Prevention. State-specific second hand smoke exposure and current cigarette smoking among adults-United States 2008. MMWR Morb Mortal Wkly Rep 58 (2009), 1232–1235.
27. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI)trial. Phase I findings. N Engl J Med 312 (1985), 932–936.
28. Gibson, C.M., Cannon, C.P., Daley, W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996), 879–888.
29. Gibson, C.M., Karha, J., Giugliano, R.P., et al., for the INTEGRITI Study Group. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. Am Heart J 147 (2004), 847–852.
30. Kramer, C.M., Barkhausen, J., Flamm, S.D., Kim, R.J., Nagel, E., Standardized cardiovascular magnetic resonance (CMR)protocols 2013 update. J Cardiovasc Magn Reson, 15, 2013, 91.
31. Giri, S., Chung, Y.C., Merchant, A., et al. Direct T2 quantification of myocardial edema in acute ischemic injury. J Cardiovasc Magn Reson, 11, 2009, 56.
32. Verhaert, D., Thavendiranathan, P., Giri, S., et al. Direct T2 quantification of myocardial edema in acute ischemic injury. J Am Coll Cardiol Img 4 (2011), 269–278.
33. Kellman, P., Arai, A.E., McVeigh, E.R., Aletras, A.H., Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 47 (2002), 372–383.
34. Flett, A.S., Hasleton, J., Cook, C., et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. J Am Coll Cardiol Img 4 (2011), 150–156.
35. Anderson, L.J., Holden, S., Davis, B., et al. Cardiovascular T2-star (T2*)magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22 (2001), 2171–2179.
36. Eitel, I., Desch, S., Fuernau, G., et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 55 (2010), 2470–2479.
37. Berry, C., Kellman, P., Mancini, C., et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging 3 (2010), 527–535.
38. Payne, A.R., Casey, M., McClure, J., et al. Bright-blood T2-weighed MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage. Circ Cardiovasc Imaging 4 (2011), 210–219.
39. Francone, M., Bucciarelli-Ducci, C., Carbone, I., et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 54 (2009), 2145–2153.
40. Carrick, D., Haig, C., Rauhalammi, S., et al. Pathophysiology of LV remodeling in survivors of STEMI: inflammation, remote myocardium and prognosis. J Am Coll Cardiol Img 8 (2015), 779–789.
41. Hicks, K.A., Tcheng, J.E., Bockurt, B., et al. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoints events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 66 (2015), 403–469.
42. Symons, R., Pontone, G., Schwitter, J., et al. Long-term incremental prognostic value of cardiovascular magnetic resonance after ST-segment elevation myocardial infarction: a study of the collaborative registry on CMR in STEMI. J Am Coll Cardiol Img 11 (2018), 813–825.
43. de Lemos, J.A., Morrow, D.A., Sabatine, M.S., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107 (2003), 690–695.
44. Lyngbakken, M.N., Skranes, J.B., de Lemos, J.A., et al. Impact of smoking on circulating cardiac troponin- concentrations and cardiovascular events in the general population: the HUNT study (Nord-Trøndelag Health Study). Circulation 134 (2016), 1962–1972.